A low-molecular-weight inhibitor against the chemokine receptor CXCR4: A strong anti-HIV peptide T140

被引:279
作者
Tamamura, H [1 ]
Xu, YO
Hattori, T
Zhang, XY
Arakaki, R
Kanbara, K
Omagari, A
Otaka, A
Ibuka, T
Yamamoto, N
Nakashima, H
Fujii, N
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan
[3] Kagoshima Univ, Sch Dent, Kagoshima 8908544, Japan
[4] Tokyo Med & Dent Univ, Sch Med, Bunkyo Ku, Tokyo 1138519, Japan
关键词
D O I
10.1006/bbrc.1998.9871
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T22 ([Tyr(5,12), Lys(7)]-polyphemusin II) is an 18-residue peptide amide, which has strong anti-MN activity. T22 inhibits the T cell line-tropic (T-tropic) HIV-1 infection through its specific binding to a chemokine receptor CXCR4, which serves as a coreceptor for the entry of T-tropic HIV-1 strains. Herein, we report our finding of novel 14-residue CXCR4 inhibitors, T134 and T140, on the basis of the T22 structure. In the assays we examined, T140 showed the highest inhibitory activity against HIV-1 entry and the strongest inhibitory effect on the binding of an anti-CXCR4 monoclonal antibody (12G5) to CXCR4 among all the CXCR4 inhibitors that have been reported up to now. (C) 1998 Academic Press.
引用
收藏
页码:877 / 882
页数:6
相关论文
共 39 条
  • [1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
    Alkhatib, G
    Combadiere, C
    Broder, CC
    Feng, Y
    Kennedy, PE
    Murphy, PM
    Berger, EA
    [J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958
  • [2] HIV blocked by chemokine antagonist
    ArenzanaSeisdedos, F
    Virelizier, JL
    Rousset, D
    ClarkLewis, I
    Loetscher, P
    Moser, B
    Baggiolini, M
    [J]. NATURE, 1996, 383 (6599) : 400 - 400
  • [3] New hope in HIV disease
    Balter, M
    [J]. SCIENCE, 1996, 274 (5295) : 1988 - 1989
  • [4] The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
    Bleul, CC
    Farzan, M
    Choe, H
    Parolin, C
    ClarkLewis, I
    Sodroski, J
    Springer, TA
    [J]. NATURE, 1996, 382 (6594) : 829 - 833
  • [5] Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity
    Brelot, A
    Heveker, N
    Pleskoff, O
    Sol, N
    Alizon, M
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (06) : 4744 - 4751
  • [6] The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
    Choe, H
    Farzan, M
    Sun, Y
    Sullivan, N
    Rollins, B
    Ponath, PD
    Wu, LJ
    Mackay, CR
    LaRosa, G
    Newman, W
    Gerard, N
    Gerard, C
    Sodroski, J
    [J]. CELL, 1996, 85 (07) : 1135 - 1148
  • [7] AN INFECTIOUS MOLECULAR CLONE OF AN UNUSUAL MACROPHAGE-TROPIC AND HIGHLY CYTOPATHIC STRAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    COLLMAN, R
    BALLIET, JW
    GREGORY, SA
    FRIEDMAN, H
    KOLSON, DL
    NATHANSON, N
    SRINIVASAN, A
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (12) : 7517 - 7521
  • [8] VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES
    CONNOR, RI
    CHEN, BK
    CHOE, S
    LANDAU, NR
    [J]. VIROLOGY, 1995, 206 (02) : 935 - 944
  • [9] Identification of a major co-receptor for primary isolates of HIV-1
    Deng, HK
    Liu, R
    Ellmeier, W
    Choe, S
    Unutmaz, D
    Burkhart, M
    DiMarzio, P
    Marmon, S
    Sutton, RE
    Hill, CM
    Davis, CB
    Peiper, SC
    Schall, TJ
    Littman, DR
    Landau, NR
    [J]. NATURE, 1996, 381 (6584) : 661 - 666
  • [10] AMD310, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
    Donzella, GA
    Schols, D
    Lin, SW
    Esté, JA
    Nagashima, KA
    Maddon, PJ
    Allaway, GP
    Sakmar, TP
    Henson, G
    De Clercq, E
    Moore, JP
    [J]. NATURE MEDICINE, 1998, 4 (01) : 72 - 77